Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-month Results from a Phase 1 Study

Author:Henchcliffe, Claire   Sarva, Harini   Lozano, Andres   Fasano, Alfonso   Kalia, Suneil   Yu, Kenny Kwok Hei   Brennan, Cameron   stemple, Whitney   Abid, Nauman   Yountz, Marcus   Enayetallah, Ahmed   Lampron, Antoine   Tabar, Viviane   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.007  

Author Institution:University of California, Irvine, Orange, CA  Weill Cornell Medical Center, New York, NY  Toronto Western Hosp, Toronto, ON, Canada  Toronto Western Hospital - U of Toronto, Toronto, ON, Canada  University of Toronto, Toronto, ON, Canada  Memorial Sloan Kettering Cancer Center, New York, NY  BlueRock Therapeutics, Cambridge, MA